Product Information
SULFACETAMIDE-SULFUR 9-4% CLSR is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.2478 per ML under NDC 58657047316. Its NADAC has been published 129 times since Apr 17, 2024.
Strength
90; 40 mg/mL; mg/mL
Manufacturer
Method Pharmaceuticals LLCNDC
58657047316
Classification
Generic
Dosage Form
LIQUID
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE-SULFUR 9-4% CLSR has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 78.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2478 per ML |
|---|---|
| All-time high | $0.3766 (May 13, 2026) |
| All-time low | $0.1299 (Jul 17, 2024) |
| 52-week high | $0.3766 |
| 52-week low | $0.1794 |
| Median price | $0.1736 |
| Average price | $0.2073 |
| Largest weekly change | +63.6% (Apr 22, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SULFACETAMIDE SODIUM, SULFUR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SULFACETAMIDE SODIUM, SULFUR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE-SULFUR 9-4% CLSR?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE-SULFUR 9-4% CLSR, manufactured by Method Pharmaceuticals LLC, is $0.2478 per ML (NDC 58657047316), effective Sep 30, 2026.
How has the price of SULFACETAMIDE-SULFUR 9-4% CLSR changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE-SULFUR 9-4% CLSR has risen 78.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE-SULFUR 9-4% CLSR?
Since Apr 17, 2024, the NADAC for SULFACETAMIDE-SULFUR 9-4% CLSR has ranged from a low of $0.1299 (Jul 17, 2024) to a high of $0.3766 (May 13, 2026), with a median of $0.1736 per ML.
Are there cheaper alternatives to SULFACETAMIDE-SULFUR 9-4% CLSR?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE-SULFUR 9-4% CLSR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE-SULFUR 9-4% CLSR?
SULFACETAMIDE-SULFUR 9-4% CLSR (NDC 58657047316) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.